BIOLINERX LTD-SPONS ADR (BLRX) Stock Cash Flow
NASDAQ:BLRX - Nasdaq - US09071M2052 - ADR
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -49.15M | -60.61M | -24.95M | -27.05M | -30.02M | |||
| Depreciation Amortization | 2.02M | 1.38M | 654.00K | 703.00K | 934.00K | |||
| Change In Working Capital | 4.16M | 15.20M | 1.24M | -540.00K | -1.29M | |||
| Interest Paid | 1.05M | 1.11M | 593.00K | 682.00K | 994.00K | |||
| Other non cash items | 14.27M | 21.42M | -3.18M | 3.32M | 7.17M | |||
| OPERATING CASH FLOW | -28.70M | -22.61M | -26.24M | -23.57M | -23.21M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -200.00K | -297.00K | -316.00K | -97.00K | 0.00 | |||
| Other Investing Activity | 11.69M | 1.74M | 4.32M | -38.13M | 16.67M | |||
| INVESTING CASH FLOW | 11.49M | 1.44M | 4.01M | -38.22M | 16.67M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.83M | -1.99M | 6.07M | -3.57M | -3.36M | |||
| Stock Issued/Repurchased | N/A | 17.04M | 14.36M | 61.32M | 21.22M | |||
| FINANCING CASH FLOW | 14.21M | 15.06M | 20.44M | 57.75M | 17.87M | |||
| Exchange Rate Effect | -75.00K | -224.00K | -607.00K | 207.00K | 206.00K | |||
| CHANGE IN CASH | -3.08M | -6.33M | -2.40M | -3.84M | 11.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -28.70M | -22.61M | -26.24M | -23.57M | -23.21M | |||
| Capital Expenditure | -200.00K | -297.00K | -316.00K | -97.00K | 0.00 | |||
| FREE CASH FLOW | -28.90M | -22.91M | -26.56M | -23.67M | -23.21M | |||
All data in USD